<DOC>
	<DOCNO>NCT02645747</DOCNO>
	<brief_summary>The objective retrospective chart review evaluate drug utilization , usage pattern indication effectiveness Eylea routine clinical ( real-life ) management patient suffer ME ( Macular Edema ) , secondary CRVO ( Central Retinal Vein Occlusion ) , start treatment Eylea indication .</brief_summary>
	<brief_title>Retrospective Data Analysis Patients Treated Macular Edema Due Central Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>Male female adult patient suffer visual impairment due ME secondary CRVO AntiVEGF treatmentnaive patient start reimbursed Eylea treatment 1st June 2014 28th February 2015 Patients diagnose neovascular glaucoma secondary CRVO exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>